The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Lisa Sengeløv

Department of Oncology

Herlev University Hospital

Denmark

[email]@dadlnet.dk

Name/email consistency: high

[Claim this account]

Affiliations

Department of Oncology, Herlev University Hospital, Denmark. 1998 - 2002
Oncology Clinic, The Finsen Center, Rigshospitalet, Copenhagen, Denmark. 2000

References

Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumours. Sengeløv, L., von der Maase, H., Lundbeck, F., Barlebo, H., Colstrup, H., Engelholm, S.A., Krarup, T., Madsen, E.L., Meyhoff, H.H., Mommsen, S., Nielsen, O.S., Pedersen, D., Steven, K., Sørensen, B. Acta. Oncol (2002) [Pubmed]
Metastatic urothelial cancer: evaluation of prognostic factors and change in prognosis during the last twenty years. Sengeløv, L., Kamby, C., von der Maase, H. Eur. Urol. (2001) [Pubmed]
Predictive factors of response to cisplatin-based chemotherapy and the relation of response to survival in patients with metastatic urothelial cancer. Sengeløv, L., Kamby, C., Geertsen, P., Andersen, L.J., von der Maase, H. Cancer Chemother. Pharmacol. (2000) [Pubmed]
Docetaxel and cisplatin in metastatic urothelial cancer: a phase II study. Sengeløv, L., Kamby, C., Lund, B., Engelholm, S.A. J. Clin. Oncol. (1998) [Pubmed]